Previous Issues

Newsletter Archive

In This Issue

Our newest Student Chapter hit the ground running in December with a plant tour of Abbott and is already planning an exciting mix of educational and professional events for the upcoming semester...

• PCI Synthesis Continues Devens Expansion - Read the full story . . .
• Genzyme and Cystic Fibrosis Foundation Therapeutics Form Collaboration - Read the full story . . .
• Genzyme Appoints Leaders for Multiple Sclerosis and Rare Disease Businesses - Read the full story . . .
• Genzyme Plans to Grow in Massachusetts - Read the full story . . .
• Vertex Announces CEO Succession Plan for 2012 - Read the full story . . .
• FDA Grants Vertex Priority Review for Drug Treating Cystic Fibrosis - Read the full story . . .
• Covidien Plans Spin-Off of Pharmaceuticals Business - Read the full story . . .

• FDA Approves First Generic Olanzapine to Treat Schizophrenia and Bipolar Disorder  - Read the full story . . .
• FDA Invests $2 Million in Partnerships through Centers of Excellence in Regulatory Science and Innovation - Read the full story . . .
• FDA Approves 35 Innovative New Drugs in Fiscal Year 2011 - Read the full story . . .
• FDA Approves Xarelto to Prevent Stroke - Read the full story . . .
• FDA Approves Erbitux to Treat Late-Stage Head and Neck Cancer - Read the full story . . .
• FDA Approves First Drug to Treat a Rare Bone Marrow Disease - Read the full story . . .
• FDA Revokes Approval of Genentech's Avastin for Breast Cancer - Read the full story . . .
• FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor  - Read the full story . . .
• FDA Proposes Draft Guidelines to Improve the Representation of Women in Medical Device Clinical Studies - Read the full story . . .
• FDA Accepts Eliquis (apixaban) New Drug Application for Review  - Read the full story . . .